Treace Medical Concepts, Inc. (TMCI)

NMS – Цена в реальном времени. Валюта: USD

4.46

+0.01 (0.22%)

При закрытии: Jun 26, 2026, 4:00 PM EDT

4.46

+0.00 (0.00%)

После закрытия: Jun 26, 2026, 4:31 PM EDT

11.06.2026

Treace to Present at the Sidoti Small Cap Conference

PONTE VEDRA, Fla., June 11, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced it will present at the Sidoti Small Cap Conference, Thursday, June 18, 2026, beginning at approximately 1:45 pm ET.

12.05.2026

Treace Medical Concepts, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

SAN DIEGO, May 12, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Treace Medical Concepts, Inc. (NASDAQ: TMCI). The investigation focuses on Treace's executive officers and whether investor losses may be recovered under federal securities laws.

09.05.2026

Treace Medical Concepts Q1 Earnings Call Highlights

Treace Medical Concepts NASDAQ: TMCI reaffirmed its full-year 2026 revenue outlook after reporting a first-quarter revenue decline, as management said new product adoption is helping drive procedure volume momentum despite pricing and mix headwinds.

08.05.2026

Treace Medical Concepts, Inc. (TMCI) Q1 2026 Earnings Call Transcript

08.05.2026

Treace Medical Concepts (TMCI) Reports Q1 Loss, Beats Revenue Estimates

Treace Medical Concepts (TMCI) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.31. This compares to a loss of $0.25 per share a year ago.

08.05.2026

Treace Medical Concepts Reports First Quarter 2026 Financial Results

PONTE VEDRA, Fla., May 08, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today reported financial results for the first quarter ended March 31, 2026.

24.04.2026

Treace to Report First Quarter 2026 Financial Results on May 8, 2026

PONTE VEDRA, Fla., April 24, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced that it will release financial results for the first quarter 2026 before the start of trading on Friday, May 8, 2026. Company management will host a conference call to discuss financial results beginning at 8:00 am ET.

Видео

No Data

There is no data to display

Пресс-релизы

12.05.2026

Treace Medical Concepts, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

08.05.2026

Treace Medical Concepts Reports First Quarter 2026 Financial Results

07.04.2026

Treace Announces First Surgical Cases with the SuperBite™ Compression Screw System

New portfolio addition taps into incremental procedures throughout the foot and ankle; strengthens Treace's comprehensive suite of technologies for its growing customer base New portfolio addition taps into incremental procedures throughout the foot and ankle; strengthens Treace's comprehensive suite of technologies for its growing customer base

27.02.2026

Treace Medical Concepts Reports Fourth Quarter and Full-Year 2025 Financial Results

PONTE VEDRA, Fla., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today reported financial results for the fourth quarter and full-year ended December 31, 2025.

Treace Medical Concepts, Inc. (TMCI)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Treace Medical Concepts, Inc. (TMCI)

Treace to Present at the Sidoti Small Cap Conference

Treace Medical Concepts, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

Treace Medical Concepts Q1 Earnings Call Highlights

Treace Medical Concepts, Inc. (TMCI) Q1 2026 Earnings Call Transcript

Treace Medical Concepts (TMCI) Reports Q1 Loss, Beats Revenue Estimates

Treace Medical Concepts Reports First Quarter 2026 Financial Results

Treace to Report First Quarter 2026 Financial Results on May 8, 2026

Видео

No Data

Пресс-релизы

Treace Medical Concepts, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

Treace Medical Concepts Reports First Quarter 2026 Financial Results

Treace Announces First Surgical Cases with the SuperBite™ Compression Screw System

Treace Medical Concepts Reports Fourth Quarter and Full-Year 2025 Financial Results

Treace to Present at the Sidoti Small Cap Conference

Treace Medical Concepts, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

Treace Medical Concepts Q1 Earnings Call Highlights

Treace Medical Concepts, Inc. (TMCI) Q1 2026 Earnings Call Transcript

Treace Medical Concepts (TMCI) Reports Q1 Loss, Beats Revenue Estimates

Treace Medical Concepts Reports First Quarter 2026 Financial Results

Treace to Report First Quarter 2026 Financial Results on May 8, 2026

Видео

No Data

Пресс-релизы

Treace Medical Concepts, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

Treace Medical Concepts Reports First Quarter 2026 Financial Results

Treace Announces First Surgical Cases with the SuperBite™ Compression Screw System

Treace Medical Concepts Reports Fourth Quarter and Full-Year 2025 Financial Results

Search stocks

Treace Medical Concepts, Inc. (TMCI)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Treace Medical Concepts, Inc. (TMCI)

Treace to Present at the Sidoti Small Cap Conference

Treace Medical Concepts, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

Treace Medical Concepts Q1 Earnings Call Highlights

Treace Medical Concepts, Inc. (TMCI) Q1 2026 Earnings Call Transcript

Treace Medical Concepts (TMCI) Reports Q1 Loss, Beats Revenue Estimates

Treace Medical Concepts Reports First Quarter 2026 Financial Results

Treace to Report First Quarter 2026 Financial Results on May 8, 2026

Видео

No Data

Пресс-релизы

Treace Medical Concepts, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

Treace Medical Concepts Reports First Quarter 2026 Financial Results

Treace Announces First Surgical Cases with the SuperBite™ Compression Screw System

Treace Medical Concepts Reports Fourth Quarter and Full-Year 2025 Financial Results

Treace to Present at the Sidoti Small Cap Conference

Treace Medical Concepts, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

Treace Medical Concepts Q1 Earnings Call Highlights

Treace Medical Concepts, Inc. (TMCI) Q1 2026 Earnings Call Transcript

Treace Medical Concepts (TMCI) Reports Q1 Loss, Beats Revenue Estimates

Treace Medical Concepts Reports First Quarter 2026 Financial Results

Treace to Report First Quarter 2026 Financial Results on May 8, 2026

Видео

No Data

Пресс-релизы

Treace Medical Concepts, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

Treace Medical Concepts Reports First Quarter 2026 Financial Results

Treace Announces First Surgical Cases with the SuperBite™ Compression Screw System

Treace Medical Concepts Reports Fourth Quarter and Full-Year 2025 Financial Results